CN108841949A - 帕金森病早期检测和诊断试剂盒及装置 - Google Patents
帕金森病早期检测和诊断试剂盒及装置 Download PDFInfo
- Publication number
- CN108841949A CN108841949A CN201810753754.2A CN201810753754A CN108841949A CN 108841949 A CN108841949 A CN 108841949A CN 201810753754 A CN201810753754 A CN 201810753754A CN 108841949 A CN108841949 A CN 108841949A
- Authority
- CN
- China
- Prior art keywords
- chchd2
- gene
- parkinson
- seq
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 69
- 208000018737 Parkinson disease Diseases 0.000 title claims abstract description 45
- 238000009007 Diagnostic Kit Methods 0.000 title claims abstract description 13
- 230000014509 gene expression Effects 0.000 claims abstract description 59
- 101150055789 CHCHD2 gene Proteins 0.000 claims abstract description 58
- 101100167060 Homo sapiens CHCHD2 gene Proteins 0.000 claims abstract description 58
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 37
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 7
- 239000000523 sample Substances 0.000 claims description 58
- 102100023692 Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 Human genes 0.000 claims description 35
- 101000906986 Homo sapiens Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 Proteins 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 101150078398 Ahsp gene Proteins 0.000 claims description 25
- 239000002773 nucleotide Substances 0.000 claims description 24
- 125000003729 nucleotide group Chemical group 0.000 claims description 24
- 238000003745 diagnosis Methods 0.000 claims description 22
- 102100032381 Alpha-hemoglobin-stabilizing protein Human genes 0.000 claims description 15
- 101000797984 Homo sapiens Alpha-hemoglobin-stabilizing protein Proteins 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000003757 reverse transcription PCR Methods 0.000 claims description 7
- 238000011529 RT qPCR Methods 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 238000007901 in situ hybridization Methods 0.000 claims description 6
- 238000003499 nucleic acid array Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102100034343 Integrase Human genes 0.000 claims description 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 claims 1
- 229940085503 testred Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 238000012360 testing method Methods 0.000 abstract description 7
- 238000007405 data analysis Methods 0.000 abstract description 5
- 238000013399 early diagnosis Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 8
- 239000000090 biomarker Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 230000003321 amplification Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000012474 protein marker Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102100037991 85/88 kDa calcium-independent phospholipase A2 Human genes 0.000 description 1
- 101150037123 APOE gene Proteins 0.000 description 1
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102100026882 Alpha-synuclein Human genes 0.000 description 1
- 102100029470 Apolipoprotein E Human genes 0.000 description 1
- 102100022207 E3 ubiquitin-protein ligase parkin Human genes 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102100031690 Erythroid transcription factor Human genes 0.000 description 1
- 102100039735 Eukaryotic translation initiation factor 4 gamma 1 Human genes 0.000 description 1
- 102100029525 F-box only protein 7 Human genes 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 1
- 101001066268 Homo sapiens Erythroid transcription factor Proteins 0.000 description 1
- 101001034825 Homo sapiens Eukaryotic translation initiation factor 4 gamma 1 Proteins 0.000 description 1
- 101000917536 Homo sapiens F-box only protein 7 Proteins 0.000 description 1
- 101000891579 Homo sapiens Microtubule-associated protein tau Proteins 0.000 description 1
- 101000887201 Homo sapiens Polyamine-transporting ATPase 13A2 Proteins 0.000 description 1
- 101000617536 Homo sapiens Presenilin-1 Proteins 0.000 description 1
- 101000617546 Homo sapiens Presenilin-2 Proteins 0.000 description 1
- 101000605835 Homo sapiens Serine/threonine-protein kinase PINK1, mitochondrial Proteins 0.000 description 1
- 101000617808 Homo sapiens Synphilin-1 Proteins 0.000 description 1
- 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 description 1
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 description 1
- 102100040243 Microtubule-associated protein tau Human genes 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 101710125553 PLA2G6 Proteins 0.000 description 1
- 102100039917 Polyamine-transporting ATPase 13A2 Human genes 0.000 description 1
- 102100022033 Presenilin-1 Human genes 0.000 description 1
- 102100022036 Presenilin-2 Human genes 0.000 description 1
- 102000007659 Protein Deglycase DJ-1 Human genes 0.000 description 1
- 108010032428 Protein Deglycase DJ-1 Proteins 0.000 description 1
- 102100038376 Serine/threonine-protein kinase PINK1, mitochondrial Human genes 0.000 description 1
- 102100021997 Synphilin-1 Human genes 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 102100022563 Tubulin polymerization-promoting protein Human genes 0.000 description 1
- 101710158555 Tubulin polymerization-promoting protein Proteins 0.000 description 1
- 102000005918 Ubiquitin Thiolesterase Human genes 0.000 description 1
- 108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 210000004002 dopaminergic cell Anatomy 0.000 description 1
- 210000005064 dopaminergic neuron Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002796 luminescence method Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000019581 neuron apoptotic process Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
SuperScriptTMIII RT逆转录酶/PlatinumTMTaq酶混合物 | |
2X mix buffer | 含0.2mM dNTPs,3mM MgS04 |
CHCHD2探针 | 200nM |
CHCHD2上、下游引物对 | 各500nM |
AHSP探针 | 200nM |
AHSP上、下游引物对 | 各500nM |
液滴稳定剂 | 1x |
H2O |
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810753754.2A CN108841949B (zh) | 2018-07-10 | 2018-07-10 | 帕金森病早期检测和诊断试剂盒及装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810753754.2A CN108841949B (zh) | 2018-07-10 | 2018-07-10 | 帕金森病早期检测和诊断试剂盒及装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108841949A true CN108841949A (zh) | 2018-11-20 |
CN108841949B CN108841949B (zh) | 2021-03-02 |
Family
ID=64196078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810753754.2A Active CN108841949B (zh) | 2018-07-10 | 2018-07-10 | 帕金森病早期检测和诊断试剂盒及装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108841949B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111454960A (zh) * | 2020-04-10 | 2020-07-28 | 四川大学华西医院 | 一种检测帕金森病的诊断试剂盒 |
WO2022134225A1 (zh) * | 2020-12-25 | 2022-06-30 | 武汉睿健医药科技有限公司 | Dpc细胞鉴定分类用标记物基因、筛选方法及应用 |
CN115029428A (zh) * | 2022-05-27 | 2022-09-09 | 四川省医学科学院·四川省人民医院 | 基于口腔黏膜pink1基因的颞下颌关节骨关节病辅助诊断、预后评价试剂盒及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016086787A (ja) * | 2014-11-11 | 2016-05-23 | 学校法人順天堂 | パーキンソン病の診断 |
US20160244833A1 (en) * | 2015-02-25 | 2016-08-25 | Rosalind Franklin University Of Medicine And Science | Methods and kits for diagnosing, prognosing and monitoring parkinson's disease |
CN107419008A (zh) * | 2017-06-26 | 2017-12-01 | 上海惠皓医疗科技有限公司 | 一种早期精确诊断帕金森病的方法和试剂盒 |
-
2018
- 2018-07-10 CN CN201810753754.2A patent/CN108841949B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016086787A (ja) * | 2014-11-11 | 2016-05-23 | 学校法人順天堂 | パーキンソン病の診断 |
US20160244833A1 (en) * | 2015-02-25 | 2016-08-25 | Rosalind Franklin University Of Medicine And Science | Methods and kits for diagnosing, prognosing and monitoring parkinson's disease |
CN107419008A (zh) * | 2017-06-26 | 2017-12-01 | 上海惠皓医疗科技有限公司 | 一种早期精确诊断帕金森病的方法和试剂盒 |
Non-Patent Citations (2)
Title |
---|
HONGRUI MENG等: "Loss of Parkinsons disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c", 《NATURE COMMUNICATIONS》 * |
MANABU FUNAYAMA等: "CHCHD2 mutations in autosomal dominant late-onset Parkinsons disease: a genome-wide linkage and sequencing study", 《THE LANCET NEUROLOGY》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111454960A (zh) * | 2020-04-10 | 2020-07-28 | 四川大学华西医院 | 一种检测帕金森病的诊断试剂盒 |
CN111454960B (zh) * | 2020-04-10 | 2022-02-15 | 四川大学华西医院 | 一种检测帕金森病的诊断试剂盒 |
WO2022134225A1 (zh) * | 2020-12-25 | 2022-06-30 | 武汉睿健医药科技有限公司 | Dpc细胞鉴定分类用标记物基因、筛选方法及应用 |
CN115029428A (zh) * | 2022-05-27 | 2022-09-09 | 四川省医学科学院·四川省人民医院 | 基于口腔黏膜pink1基因的颞下颌关节骨关节病辅助诊断、预后评价试剂盒及其应用 |
CN115029428B (zh) * | 2022-05-27 | 2023-08-15 | 四川省医学科学院·四川省人民医院 | 基于口腔黏膜pink1基因的颞下颌关节骨关节病辅助诊断、预后评价试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN108841949B (zh) | 2021-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2904118B1 (en) | Urine exosome mrnas and methods of using same to detect diabetic nephropathy | |
EP3356556A2 (en) | A method for diagnosing a disease by detection of circrna in bodily fluids | |
Hervé et al. | Translational identification of transcriptional signatures of major depression and antidepressant response | |
Sun et al. | Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy | |
BR112013033488B1 (pt) | Métodos para facilitar o diagnóstico do comprometimento cognitivo devido a doença de alzheimer ou comprometimento cognitivo leve (mci)e kit | |
EP3660172A1 (en) | Method for detection of traumatic brain injury (tbi) | |
CN108841949A (zh) | 帕金森病早期检测和诊断试剂盒及装置 | |
Yan et al. | Screening the expression of several miRNAs from TaqMan Low Density Array in traumatic brain injury: miR‐219a‐5p regulates neuronal apoptosis by modulating CCNA2 and CACUL1 | |
EP3311174B1 (fr) | Méthode de diagnostic des troubles causés par l'alcoolisation foetale | |
EP3878978A1 (en) | Detection of brain cancer | |
US20180044733A1 (en) | Circulatory MicroRNAs (miRNAs) as Biomarkers for Diabetic Retinopathy (DR) and Age-Related Macular Degeneration | |
Gecys et al. | Circulating hsa-let-7e-5p and hsa-miR-125a-5p as possible biomarkers in the diagnosis of major depression and bipolar disorders | |
CN109136358A (zh) | 鉴别诊断NOA患者睾丸内残存精子的试剂及miRNA在其中的应用 | |
WO2016117582A1 (ja) | miRNAを用いた精神疾患判定マーカー | |
CN104962654B (zh) | lncRNA-MALAT1在制备增生性玻璃体视网膜病变诊断试剂中的应用 | |
CN109439744A (zh) | 重症哮喘诊断用分子标志物 | |
CN108034707B (zh) | Spag7基因在制备老年痴呆诊断制剂中的应用 | |
CN109735612A (zh) | 川崎病冠状动脉瘤并发症的生物分子标志物及其试剂盒 | |
CN104984363B (zh) | Zmym1在制备帕金森诊疗试剂中的应用 | |
CN107447008A (zh) | 用于诊断不明原因复发性流产的增强子rna组合、引物组及应用和试剂盒 | |
CN107937515A (zh) | 一种阿尔茨海默的诊疗基因靶点及其应用 | |
WO2022066617A1 (en) | Reagents, methods and kits for identifying pregnant human beings at risk for placental bed disorder(s) | |
US20220177967A1 (en) | Reagents, methods and kits for identifying pregnant human beings at risk for placental bed disorder(s) | |
JP6541049B2 (ja) | 筋萎縮性側索硬化症のバイオマーカー | |
CN104818270A (zh) | 焦虑症生物标记物、筛选方法及试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Xiaodan Inventor after: Wang Qilong Inventor before: Zhang Jing Inventor before: Liu Xiaodan Inventor before: Wang Qilong |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231107 Address after: 17th Floor, Block B, Cambridge Commune, No. 789 Shenhua Road, Xihu District, Hangzhou City, Zhejiang Province, 310012 Patentee after: Zhejiang Bauhinia Biotechnology Co.,Ltd. Address before: 100871 No. 5, the Summer Palace Road, Beijing, Haidian District Patentee before: Peking University |
|
TR01 | Transfer of patent right |